Digital therapeutic program combining dance and music for chronic neurological disorders
Official title: DANCE REhabilitation Experience (DANCEREX-DTx): Protocol for a Randomized Controlled Trial on Effectiveness of Digital Therapeutics in Chronic Neurological Disabilities
Run by Fondazione Don Carlo Gnocchi ETS · NCT06112639 · Data updated 2026-11-12
This study is testing a new dance and music program to see if it can help people with Multiple Sclerosis and early signs of cognitive decline feel better and improve their daily life.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 85 Years |
| Sex | All |
| Enrollment | 192 (estimated) |
| Sponsor | Fondazione Don Carlo Gnocchi ETS Academic / other |
| Locations | 3 sites (Brescia and 2 other locations) |
| Status | Recruiting |
| Started | January 31, 2024 |
| Main results expected | May 1, 2025 |
| Study ends | October 31, 2025 |
| Registry record updated | January 10, 2025 |
| Trial ID | NCT06112639 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include adults aged 18 to 85 with a diagnosis of Multiple Sclerosis or pre-Mild Cognitive Impairment.
✕Probably not a fit
Patients with comorbidities that hinder participation in a home program, such as severe balance issues or a history of falls, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the efficacy of a new digital therapeutic solution called DANCEREX-DTx, which integrates a multidimensional rehabilitation program based on dance and music with a motivational system. Participants will be randomized into three groups: one receiving the DANCEREX program, another receiving a dance-based program without the motivational component, and a placebo group receiving an educational program. The study will assess adherence, clinical and functional measures, quality of life, and the usability and acceptability of the system among individuals with Multiple Sclerosis and pre-Mild Cognitive Impairment. The trial seeks to provide insights into the potential benefits of dance-based rehabilitation in improving cognitive and functional outcomes.
Why it matters
Potential benefit: If successful, this approach could enhance the quality of life and cognitive function for patients with chronic neurological disorders.
How similar studies have gone: While the specific approach of combining dance and music in a digital therapeutic context is novel, similar rehabilitation methods have shown promise in improving outcomes for patients with neurological conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. age between 18 and 85 years (adult and older adult); 2. education equal to or more than five years 3. agreement to participate with the signature of the informed consent form; 4. clinical diagnosis of Multiple Sclerosis (MS) according to the 2017 revised criteria of MC Donald - Expanded Disability Status Scale (EDSS) score equal or less than 4.5, R-R disease course, freedom from relapses, and steroid treatment for at least one month, OR clinical diagnosis of pre-Mild Cognitive Impairment - MCI (Subjective Memory Complaints and/or Subjective Cognitive Complaints)/MCI at risk of Alzheimer's Disease with the Clinical Dementia Rating (CDR) scale equal or less than 0.5 5. Normal score to a screening test for cognitive impairment (Montreal Cognitive Assessment test - MoCA test \> 15.5 Santangelo et al., 2015) Exclusion Criteria: 1. presence of comorbidities that prevent patients from undertaking a safe home program (e.g., balance problems, history of falls in the past 6 months, use of assistive devices for deambulation) 2. presence of overt hearing/visual impairment 3. for the MCI group, the absence of a caregiver/study partner able to support the participant; 4. no living in one's own home; 5. for the MS group, score in cerebellum function at EDSS greater than 3
Where it's running
-
IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli
Brescia, Italy Recruiting -
IRCCS Centro Neurolesi Bonino-Pulejo
Messina, Italy Recruiting -
IRCCS Fondazione Don Carlo Gnocchi ONLUS
Milan, Italy Recruiting
Study contacts
- Principal investigator: Maria Pia Amato — IRCCS Fondazione Don Carlo Gnocchi ONLUS
- Study coordinator: Francesca Baglio, MD
- Email: fbaglio@dongnocchi.it
- Phone: +390240308952
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Improving attention in military personnel with mild traumatic brain injury using brain stimulation and cognitive training
This study is testing a new way to help Active Duty Service Members and Veterans with mild traumatic brain injury improve their attention by combining brain stimulation with cognitive training.
-
Using memantine to protect memory and cognition during craniospinal irradiation
This study is testing if the drug memantine can help protect memory and thinking skills in patients getting radiation treatment for brain tumors.
-
Finding early biological signs of severe illness in ICU patients
The study will collect blood, lung, and rectal samples from adults newly admitted to the ICU to see if early biological signs can help diagnose and personalize care for sepsis, ARDS, or other critical illnesses.
-
Butyrate treatment for Gulf War Illness
This study is testing if a butyrate treatment can help improve physical function and reduce symptoms in Veterans with Gulf War Illness.
-
Using a passive home sensor to find digital signs of brain energy changes from nicotinamide riboside
This project will try a contact-free home sensor to see if it can detect activity, sleep, and breathing changes related to nicotinamide riboside in people with mild cognitive impairment or mild Alzheimer's.
-
Hyperbaric oxygen for long COVID cognitive and fatigue symptoms
This trial will try hyperbaric oxygen therapy versus a sham treatment to see if it helps adults with long COVID who still have thinking problems, memory issues, fatigue, or other lingering symptoms at least three months after infection.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.